Ariel E. Marciscano Adjunct Assistant Professor of Pathology and Laboratory Medicine (Courtesy)

Adjunct Assistant Professor of Pathology and Laboratory Medicine (Courtesy), Pathology and Laboratory Medicine , Weill Cornell Medical College 2023 -
Assistant Professor of Radiation Oncology, Radiation Oncology , Weill Cornell Medical College 2020 - 2023

Publications

Sort by

Co-Author Network

selected publications

Updates on radiotherapy-immunotherapy combinations: Proceedings of 6^th annual ImmunoRad conference. Oncoimmunology. 2023 Review GET IT
Times cited: 6
Radiation therapy: An old dog learning new tricks. Methods in cell biology. 2023 Academic Article GET IT
Radiation therapy: An old dog learning new tricks. Methods in cell biology. 2022 Editorial Article GET IT
Parallels Between the Antiviral State and the Irradiated State. Journal of the National Cancer Institute. 2021 Academic Article GET IT
Times cited: 6
The role of dendritic cells in cancer and anti-tumor immunity. Seminars in immunology. 2021 Information Resource GET IT
Radiation Therapy and the In Situ Vaccination Approach. International journal of radiation oncology, biology, physics. 2020 Information Resource GET IT
Times cited: 10
Clinical Outcomes of Combined Prostate- and Metastasis-Directed Radiation Therapy for the Treatment of De Novo Oligometastatic Prostate Cancer. Advances in radiation oncology. 2020 Academic Article GET IT
Times cited: 8
CDK12 Gene Alterations in Prostate Cancer: Present, but Clinically Actionable?. European urology. 2020 Editorial Article GET IT
Times cited: 1
Atypical Histopathological Features and the Risk of Treatment Failure in Nonmalignant Meningiomas: A Multi-Institutional Analysis. World neurosurgery. 2019 Academic Article GET IT
Times cited: 4
Role of noninvasive molecular imaging in determining response. Advances in radiation oncology. 2018 Review GET IT
Times cited: 22
Avelumab: is it time to get excited?. Expert review of anticancer therapy. 2018 Editorial Article GET IT
Times cited: 5
Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and Immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research. 2018 Academic Article GET IT
Times cited: 243
The Winds of Change: Emerging Therapeutics in Prostate Cancer. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2018 Review GET IT
Times cited: 1
Effects of perineural invasion on biochemical recurrence and prostate cancer-specific survival in patients treated with definitive external beam radiotherapy. Urologic oncology. 2018 Academic Article GET IT
Times cited: 8
Targeting the Tumor Microenvironment with Immunotherapy for Genitourinary Malignancies. Current treatment options in oncology. 2018 Review GET IT
Times cited: 6
TNFα and Radioresistant Stromal Cells Are Essential for Therapeutic Efficacy of Cyclic Dinucleotide STING Agonists in Nonimmunogenic Tumors. Cancer immunology research. 2018 Academic Article GET IT
Times cited: 65
Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop. Journal for immunotherapy of cancer. 2018 Conference Paper GET IT
Times cited: 21
Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma. International journal of radiation oncology, biology, physics. 2017 Academic Article GET IT
Times cited: 205
Avelumab demonstrates promise in advanced NSCLC. Oncotarget. 2017 Editorial Article GET IT
Times cited: 5
Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment. Cancer immunology research. 2017 Academic Article GET IT
Times cited: 170
Long-term Treatment Response and Patient Outcomes for Vestibular Schwannoma Patients Treated with Hypofractionated Stereotactic Radiotherapy. Frontiers in oncology. 2017 Academic Article GET IT
Times cited: 20
Long-term Outcomes With Planned Multistage Reduced Dose Repeat Stereotactic Radiosurgery for Treatment of Inoperable High-Grade Arteriovenous Malformations: An Observational Retrospective Cohort Study. Neurosurgery. 2017 Academic Article GET IT
Times cited: 9
Evaluating Post-Radiotherapy Laryngeal Function with Laryngeal Videostroboscopy in Early Stage Glottic Cancer. Frontiers in oncology. 2017 Academic Article GET IT
Times cited: 7
LAG3 (CD223) as a cancer immunotherapy target. Immunological reviews. 2017 Review GET IT
Times cited: 706
Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological grade. Neuro-oncology. 2015 Academic Article GET IT
Times cited: 101
Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes. Journal of neurosurgery. 2015 Academic Article GET IT
Times cited: 60
3D quantitative assessment of response to fractionated stereotactic radiotherapy and single-session stereotactic radiosurgery of vestibular schwannoma. European radiology. 2015 Academic Article GET IT
Times cited: 14
Antiangiogenic Therapies and Extracranial Metastasis in Glioblastoma: A Case Report and Review of the Literature. Case reports in oncological medicine. 2015 Academic Article GET IT
Times cited: 11
Development of a novel multiplexed assay for quantification of transforming growth factor-β (TGF-β). Growth factors (Chur, Switzerland). 2015 Academic Article GET IT
Times cited: 8
Stereotactic body radiation therapy in pancreatic cancer: the new frontier. Expert review of anticancer therapy. 2014 Review GET IT
Times cited: 25
Torus palatinus. 2014 GET IT
Is there a role for an external beam boost in cervical cancer radiotherapy?. Frontiers in oncology. 2013 Academic Article GET IT
Times cited: 14
Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-β. Cancer research. 2012 Academic Article GET IT
Times cited: 204
Introduction to the medical professions through an innovative medical student-run pipeline program. Journal of the National Medical Association. 2011 Academic Article GET IT
Times cited: 15

Research

Sort by

Co-investigator Network

Funding awarded

Targeting Fc gamma receptors (FcɣRs) with stereotactic radiation to reprogram myeloid-derived immune cells in the prostate tumor microenvironment Principal Investigator 2021 - 2024

Dynamics of Immune Response in Irradiated Rectal Cancer awarded by National Cancer Institute Co-Investigator 2022 - 2027

PSMA/MR-guided Stereotactic Body Radiotherapy for High Risk Prostate Cancer Co-Principal Investigator 2020 - 2025

Background

education and training

M.D., New York University School of Medicine 2012
B.S., Georgetown University 2007

Contact

full name

Ariel E. Marciscano

primary email

arm7007@med.cornell.edu

webpage

Clinical Profile